Teng, Chieh-Lin <br/><br/>
Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study.  [electronic resource] 

 -  World journal of surgical oncology  Feb 2012 
 - 41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-7819 
<br/><br/><label>Standard No.: </label>10.1186/1477-7819-10-41  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antineoplastic Agents--administration & dosage<br/>Benzenesulfonates--administration & dosage<br/>Carcinoma, Hepatocellular--drug therapy<br/>Case-Control Studies<br/>Chemotherapy, Adjuvant<br/>China<br/>Female<br/>Health Status Indicators<br/>Humans<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--drug therapy<br/>Liver Transplantation--methods<br/>Male<br/>Middle Aged<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Pyridines--administration & dosage<br/>Retrospective Studies<br/>Sorafenib<br/>Statistics as Topic<br/>Time Factors